Prime Medicine (PRME) Earnings Date, Estimates & Call Transcripts → The Gold Grab of the Century (From Colonial Metals) (Ad) Free PRME Stock Alerts $4.42 +0.12 (+2.79%) (As of 04/26/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media Earnings SummaryUpcoming Earnings DateMay. 9EstimatedActual EPS (Mar. 1) -$0.56 Missed By -$0.08 Consensus EPS (Mar. 1) -$0.48 Get Prime Medicine Earnings AlertsEnter your email address below to receive the latest news and earnings results for PRME and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePRME Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PRME Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceHas Jeff Bezos Found the Next Nvidia?If you’ve sat back and watched companies like Nvidia and AMD soar over 2,000% over the past several years… And wondered what was next… This is a fast-moving story, but if you want the chance to profit alongside Jeff Bezos in the next big tech trend, go ahead and…Click Here for Full Details Prime Medicine Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.45)($0.45)($0.45)Q2 20241($0.45)($0.45)($0.45)Q3 20241($0.46)($0.46)($0.46)Q4 20241($0.42)($0.42)($0.42)FY 20244($1.78)($1.78)($1.78)PRME Earnings Date and InformationPrime Medicine last released its quarterly earnings data on March 1st, 2024. The reported ($0.56) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.48) by $0.08. Prime Medicine has generated ($2.17) earnings per share over the last year (($2.17) diluted earnings per share). Earnings for Prime Medicine are expected to grow in the coming year, from ($1.80) to ($1.65) per share. Prime Medicine has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.Read More Prime Medicine Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Estimated)------- 3/1/2024Q4 2023($0.48)($0.56)($0.08)($0.41)--11/3/2023Q3 2023($0.45)($0.55)($0.10)($0.55)--8/7/2023Q2 2023($0.42)($0.47)($0.05)($0.47)--5/11/2023Q1 2023($0.42)($0.44)($0.02)($0.44)--3/9/2023Q4 2022($0.77)($0.56)+$0.21($0.56)-- Prime Medicine Earnings - Frequently Asked Questions When is Prime Medicine's earnings date? Prime Medicine has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on PRME's earnings history. Did Prime Medicine beat their earnings estimates last quarter? In the previous quarter, Prime Medicine (NYSE:PRME) missed the analysts' consensus estimate of ($0.48) by $0.08 with a reported earnings per share (EPS) of ($0.56). Learn more on analysts' earnings estimate vs. PRME's actual earnings. How much profit does Prime Medicine generate each year? Prime Medicine (NYSE:PRME) has a recorded net income of -$198.13 million. PRME has generated -$2.17 earnings per share over the last four quarters. What is Prime Medicine's EPS forecast for next year? Prime Medicine's earnings are expected to grow from ($1.80) per share to ($1.65) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Allogene Therapeutics Earnings Date Novavax Earnings Date Valneva Earnings Date Fate Therapeutics Earnings Date ProKidney Earnings Date Mesoblast Earnings Date Exscientia Earnings Date Cabaletta Bio Earnings Date HilleVax Earnings Date Alector Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NYSE:PRME) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prime Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
